118 related articles for article (PubMed ID: 9804395)
1. Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma.
Bamonti-Catena F; Peracchi M; Conte D; Cantalamessa L; Lorenzano E; Orsatti A; Salerno F
Clin Chem Lab Med; 1998 Sep; 36(9):709-14. PubMed ID: 9804395
[TBL] [Abstract][Full Text] [Related]
2. High plasma cardiac natriuretic peptides associated with enhanced cyclic guanosine monophosphate production in preascitic cirrhosis.
Iwao T; Oho K; Nakano R; Sakai T; Sato M; Miyamoto Y; Kumamoto M; Sakai K; Sata M; Toyonaga A
J Hepatol; 2000 Mar; 32(3):426-33. PubMed ID: 10735612
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
Kawasaki H; Uemasu J; Maeda N; Hirayama C; Kobayashi T; Sakurai H
Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
Jespersen B; Jensen L; Sørensen SS; Pedersen EB
Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
[TBL] [Abstract][Full Text] [Related]
5. Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Matsuo H
J Lab Clin Med; 1987 Jun; 109(6):706-10. PubMed ID: 3035037
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling of atrial natriuretic peptide and cyclic guanosine 3',5'-monophosphate production in patients with liver cirrhosis.
Vorderwinkler KP; Jakob G; Mair J; Judmaier G; Puschendorf B
Clin Investig; 1994 Jan; 72(2):138. PubMed ID: 8186661
[No Abstract] [Full Text] [Related]
7. Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
J Gastroenterol Hepatol; 1997 Mar; 12(3):233-6. PubMed ID: 9142641
[TBL] [Abstract][Full Text] [Related]
8. Physiologic role of endogenous human atrial natriuretic peptide in preeclamptic pregnancies.
Miyamoto S; Shimokawa H; Sumioki H; Nakano H
Am J Obstet Gynecol; 1989 Jan; 160(1):155-9. PubMed ID: 2536220
[TBL] [Abstract][Full Text] [Related]
9. Plasma atrial natriuretic peptide and cyclic nucleotide levels before and after a marathon.
Lijnen P; Hespel P; M'Buyamba-Kabangu JR; Goris M; Lysens R; Vanden Eynde E; Fagard R; Amery A
J Appl Physiol (1985); 1987 Sep; 63(3):1180-4. PubMed ID: 2820919
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.
Francavilla A; Jones AF; Starzl TE
Gastroenterology; 1978 Dec; 75(6):1026-32. PubMed ID: 213345
[TBL] [Abstract][Full Text] [Related]
11. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
12. Deranged metabolism of cyclic nucleotides in liver diseases.
Matsushima T; Maekubo H; Yoshida T; Taneda H; Yoshida J; Miyazaki T; Okada F
Horm Metab Res; 1985 Jun; 17(6):306-7. PubMed ID: 2991101
[TBL] [Abstract][Full Text] [Related]
13. Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.
Wood PJ; Ross G; Smith CL
J Clin Pathol; 1979 Oct; 32(10):998-1002. PubMed ID: 230205
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
Bald M; Bonzel KE; Rascher W
Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of the cyclic nucleotides, adenosine 3',5'-monophosphate and guanosine 3'.5'-monophosphate, in healthy adults treated with theophylline.
Fenger M; Eriksen PB; Andersen O; Nielsen MK; Knudsen PJ
Pharmacology; 1982; 24(4):215-21. PubMed ID: 6124011
[TBL] [Abstract][Full Text] [Related]
16. [Circadian changes of atrial natriuretic peptide, cyclic AMP, cyclic GMP, sodium, blood pressure and heart rate in normal subjects].
Xu CT; Wang YM
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):37-40. PubMed ID: 1326384
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
18. alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Chayvialle JA; Brissot P; Pelletier MJ; Hita de Nercy Y; Lambert R; Bourel M
Digestion; 1977; 16(1-2):118-27. PubMed ID: 79512
[TBL] [Abstract][Full Text] [Related]
19. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST
Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716
[TBL] [Abstract][Full Text] [Related]
20. On the relation of atrial natriuretic peptide and cyclic guanosine 3',5'-monophosphate plasma concentrations during ergometric exercise in healthy individuals.
Jakob G; Mair J; Puschendorf B
Horm Metab Res; 1994 Feb; 26(2):121-2. PubMed ID: 8200616
[No Abstract] [Full Text] [Related]
[Next] [New Search]
